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There is compelling evidence that lymphocytes are a recurring feature in radiation
damaged normal tissues, but assessing their functional significance has proven difficult.
Contradictory roles have been postulated in both tissue pathogenesis and protection,
although these are not necessarily mutually exclusive as the immune system can
display what may seem to be opposing faces at any one time. While the exact
role of T lymphocytes in irradiated normal tissue responses may still be obscure,
their accumulation after tissue damage suggests they may be critical targets for
radiotherapeutic intervention and worthy of further study. This is accentuated by recent
findings that pathologically damaged “self,” such as occurs after exposure to ionizing
radiation, can generate danger signals with the ability to activate pathways similar to
those that activate adoptive immunity to pathogens. In addition, the demonstration of
T cell subsets with their recognition radars tuned to “self” moieties has revolutionized
our ideas on how all immune responses are controlled and regulated. New concepts
of autoimmunity have resulted based on the dissociation of immune functions between
different subsets of immune cells. It is becoming axiomatic that the immune system has
the power to regulate radiation-induced tissue damage, from failure of regeneration to
fibrosis, to acute and chronic late effects, and even to carcinogenesis. Our understanding
of the interplay between T lymphocytes and radiation-damaged tissue may still be
rudimentary but this is a good time to re-examine their potential roles, their radiobiological
and microenvironmental influences, and the possibilities for therapeutic manipulation. This
review will discuss the yin and yang of T cell responses within the context of radiation
exposures, how they might drive or protect against normal tissue side effects and what
we may be able do about it.
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INTRODUCTION
Lymphocytes are a common component of the leukocyte infil-
trates found in irradiated tissues both during acute and chronic
phases (Hong et al., 2003; Chiang et al., 2005; Fajardo, 2005;
Yoshii, 2008; Moravan et al., 2011), and in humans and other
species (Teymoortash et al., 2005; Toma et al., 2010). While
some pathologists insist that they are unimportant as a cause of
radiation-induced damage (Fajardo, 2005), many consider them
as contributing to radiation-induced symptoms and pathogene-
sis. Strangely, both may be right! However, many lymphocytes in
irradiated lesions seem activated rather than innocently trapped
and since activated lymphocytes function as effector cells and/or
as managing directors of bystander non-immune and immune
cells through the release of effector cytokines, it is hard to ignore
their significance. In this sense, acute and late radiation effects
can be considered as acute and chronic inflammatory diseases.
Placing lymphocytes in the correct framework to understand
their possible roles; however, requires understanding of immune
recognition of “self” and how responses are controlled by allo-
cating immune functions to different T cell subsets and this will
be the focus of this review, with the understanding that other
lymphocyte subsets are present and may also be important.
The need to transplant tissues to help casualties during the
Second World War foundered on what Medawar called the
“uniqueness of the individual.” The phenomenon of transplant
rejection, however, fostered important immunological theories
based on recognition of “self”/“non-self.” Consensus grew for
antigen-driven selection and expansion of responsive lymphocyte
clones that developed so as to express a single specificity. Positive
and negative selection processes during development were postu-
lated to shape the immune repertoire so as to eliminate the chance
of autoimmunity. These theories have generally stood the test of
time. T cell repertoires are shaped in the thymus by positive selec-
tion of naive T cell clones with T cell receptors (TCR) that have
moderate affinity for self MHC antigens and that later develop
into effector T cells recognizing peptide antigen in peripheral
lymphoid organs in the context of MHC class I (CD8+ cells)
or class II (CD4+ cells). Negative selection allows those with
low affinity receptors for MHC+self to move on while those
with high affinity for “self” get deleted, probably by more than
one mechanism (central tolerance). These selection processes are,
however, far from complete and the concepts have had to be
modified to invoke mechanisms to maintain tolerance when it
became clear that anti-self reactivity was still possible (periph-
eral tolerance). This is largely the purview of Tregs, whose absence
causes severe autoimmune disease, excessive lymphoid prolifera-
tion, and immune destruction that is basically incompatible with
life. Tregs (formally known as suppressor T cells) are the major
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players in preventing excessive damage to self (Peterson, 2012),
and there is every reason to assume that they play important roles
in radiation-induced tissue damage.
T CELL SUBSETS
CD4+ naïve T cells have the capacity to differentiate along dif-
ferent paths so as to effect distinct functions following antigenic
stimulation largely through elaboration of distinct cytokine pro-
files. Initially, mutually exclusive Th1 and Th2 subsets helped
explain why cellular immunity (Th1-mediated) could exist in the
absence of antibody production (Th2-mediated) and vice-versa.
More recently, the Th17 subset, which is a potent inducer of tis-
sue inflammation and has been associated with the pathogenesis
of many autoimmune diseases, has emerged, as have adaptive
or induced Tregs (iTregs) that share participation of TGF-β in
their differentiation. Also, a Tfh subset of follicular helper cells
assists B cells in antibody production. All these “classic” T cells
become effector cells by engagement of TCRs containing α and
β chains (signal 1) and of co-stimulatory molecules (signal 2)
expressed by mature antigen presenting cells, which requires spe-
cific cytokines produced primarily by innate immune cells that
recognize molecules in a pathological site through pattern recog-
nition receptors (PRRs). Dendritic antigen presenting cells (DC)
appear to be the major drivers of these responses, but there are
others. Each T cell subset has distinct transcription factors con-
trolling their functionality and they often appear to operate in
a reciprocal fashion. One way this can occur is through inter-
conversion for example of iTregs into Th17 by IL-6. Th1 and
Th2 subsets are less flexible though they often appear to be
in opposition. The factors that drive specific T cell subsets are
the keys that unlock the enormous therapeutic of the immune
system.
In addition to these adaptive T cell subsets, natural subsets of
regulatory cells (nTregs), γδT cells, and natural killer T (NKT)
cells emerge from the thymus ready for action and bridge innate
and adaptive immunity. nTregs, like iTregs are controlled by the
Foxp3 transcription factor. They produce immunosuppressive
cytokines like TGF-β and IL-10 and both have TCRs that focus
on “self” antigens. Cells bearing TCRs composed of γ and δ
chains mostly lack CD4 and CD8 expression and are not MHC
restricted. They respond primarily to small non-peptide phos-
phoantigens, which are metabolites of isoprenoid biosynthesis
pathways. While they are found in blood, they form a more
major component of the intra-epithelial lymphocyte pool. They
are able to produce Th1-type cytokines like IFN-γ and TNF-α
and may be a major innate source of IL-17. The exact distinc-
tions between γδT cells, Th1/Th17, and nTh17 cells that are
reported in the literature are not yet clear. γδT cells, however,
form a first line of defense against Mycobacteria and Candida, as
well as being involved in anti-tumor responses and autoimmu-
nity. They have been found to accumulate around blood vessels
and mucosal airways in macaques that have inhaled Yersinia pestis
(Huang et al., 2009), where they release the homeostatic cytokine
FGF-7. This is reminiscent of perivascular cuffs of lymphocytes
often seen in radiation-damaged tissues. NKT cells, in contrast,
express an invariant and limited TCR that recognizes lipid anti-
gens presented in the context of CD1d. They play diverse roles
in enhancing some forms of cell-mediate immunity while being
more suppressive toward autoimmune responses.
The prelude to the adaptive T cell overture involves more than
just innate T cells. Ionizing radiation like other insults damages
tissues, and damaged tissues show and tell various “danger” sig-
nals including Damage-Associated Molecular Pattern molecules
(DAMPs) to the immune system (Matzinger, 2002; Shi et al.,
2003; Lotze et al., 2007; Curtin et al., 2009; Sato et al., 2009;
Kawai and Akira, 2011). DAMPs can be secreted and/or released
into extracellular spaces prior to cell death but the most dramatic
surge follows cell death with the release of HMGB1, dsDNA, chro-
matin, RNA, mitochondria, etc. It may be significant that the
conformation of intracellular molecules may change when they
are in an extracellular space with oxidation making such moi-
eties a particularly interesting source of radiation DAMPs (Miller
et al., 2011). Once released, DAMPs bind to PPRs and initiate
signaling cascades and communications between immune cells
through activation of cytokine and chemokine networks so as
hopefully to eliminate danger and restore homeostasis, leading to
regeneration and healing of tissues (Schaue and McBride, 2010;
Schaue et al., 2012). This process is characterized by infiltra-
tion of various host cells into the site—a textbook inflammatory
response—initially polymorphs and monocytes and slightly later
lymphocytes. Alterations in cellular subsets and functions with
time aim to turn the pro-inflammatory, pro-oxidant environ-
ment into one that is more compatible with tissue restoration
and rescue. In the case of radiation-damaged mucosal surfaces,
various DAMPs may actually work in cohort with microbes to
generate inflammatory infiltrates and activate innate immune
defenses (Abreu et al., 2005). A critical issue is whether the
irradiated microenvironment is sufficient to mature DCs into
competent antigen presenting cells that can activate adaptive T
cell responses (Banchereau and Steinman, 1998; Gallucci et al.,
1999). In other words, DAMPs initiate signaling cascades in DCs
that drives them to not only present the antigen to T cells (sig-
nal 1) but simultaneously to mature and to show co-stimulatory
molecules (signal 2), both of which are needed to kick off a full-
blown immune response. Conversely, antigen-presentation in the
absence of danger leads to a muted or anergic response as T cells
have been taught to ignore or are switched off by any antigen that
is not shown in the right context (Steinman et al., 2003).
The important concept that emerges is that “danger” tunes-up
the immune system to proceed in more orderly progressions to
develop a symphony involving multiple elements with feedback
through chemokine and cytokine control loops that amplify and
reiterate themes until final resolution. Adaptive immune effec-
tor T cells play major roles in perpetuating damaging processes
while Tregs and other suppressor cells calm the situation and try
to bring resolution. As a result, examination of an immune reac-
tion site may show a predominance of a particular T cell subset
and associated cytokine profile at any one time, but at least some
of the rest of the orchestra will inevitably be present with the rela-
tive contributions varying with time. Perhaps the most surprising
and exciting discovery in recent years is that the volume and the
nature of the response is under tight control primarily by Treg
cells and that their removal uncovers an immune system that is
able to participate in multiple forms of autoimmune responses,
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indicating the extent to which central tolerance is limited as a
mechanism for controlling autoimmunity. The corollary is that
the immune system is in “lock down” mode under most normal
circumstances and the generation of an effector response requires
local removal of restrictions. These concepts are highly relevant
for consideration of the role of T cells in radiation-induced nor-
mal tissue responses, just as they are for immune recognition of
tumors during radiation therapy.
SIGNS OF AUTOIMMUNITY AFTER TISSUE IRRADIATION
Damage to tissues following irradiation is a result of direct cell
kill plus collateral or bystander damage caused by vasculature
damage and inflammatory infiltrates. Initially, changes in redox
in the irradiated normal tissue microenvironment play a role
in preparing it for immune recognition and activation. This
involves decorating it with recognition molecules and release of
chemokines and chemokines and receptors that attract differ-
ent inflammatory subsets cells (Lorimore et al., 2001; Lugade
et al., 2005, 2008; Matsumura et al., 2008; Burnette et al., 2011).
We, and many others, have shown that irradiation increases
expression of MHC class I and II molecules, co-stimulatory
molecules, chemokine receptors, and other cell surface mark-
ers (Santin et al., 1996; Morel et al., 1998; Seo et al., 1999;
Garnett et al., 2004; Reits et al., 2006; Tyurina et al., 2011). The
pro-inflammatory, pro-oxidant milieu that develops in tissues
in the aftermath of irradiation is therefore one that encour-
ages immune recognition and that comes with the possibility of
autoimmunity.
Historically, autoimmunity was considered to be an aber-
rant response. More recently, it has been recognized as a nor-
mal condition with cells with potential self-reactivity existing
in everyone, even though autoimmune disease per se is rel-
atively uncommon, afflicting 5–8% of the population in the
USA. The question is whether radiation treatment generates
anti-self reactive responses, what types of response are gener-
ated, and whether they play a role in normal tissue effects.
Unfortunately such responses are easy to observe only when
they cause disease, which involves a degree of genetic sus-
ceptibility though this is not as important as environmental
factors. Autoimmune disease after radiation therapy may, how-
ever, develop more readily in people with a family history of
autoimmunity and radiation may have a more detrimental effect
in such a subpopulation. A case in point is the possible link
between autoimmune celiac disease and susceptibility to radia-
tion pneumonitis that seems to exist (Eriksen et al., 2012). In all
these discussions, the extent of the radiation field and dose are
important considerations for how irradiation alters the balance
within the immune system and how it may drive autoimmune
recognition.
The literature on radiation and autoimmunity is quite exten-
sive. Mice prone to autoimmune thyroiditis respond to whole-
body irradiation (WBI) with a higher incidence and higher
severity of the disease and higher anti-thyroglobulin autoanti-
body titers than the wild type (Nagayama et al., 2009). Humans
whose thyroids are exposed to radiation in therapeutic and
environmental settings also develop elevated autoantibodies at
least for a window of time (Brent, 2010). Other examples of
radiation-induced autoimmunity exist. Morphea, a rare but
painful skin complication in women following breast cancer
radiotherapy may be in fact due to radiation-induced neoanti-
gen formation (Laetsch et al., 2011). In a study of sialadenitis
of the submaxillary gland in head and neck cancer patients
following radiation therapy, it was concluded that acinar cell
destruction was associated with an influx of cytotoxic T cells
(Teymoortash et al., 2005). In the lung, lymphocytic alveolitis
is a marker of radiation pneumonitis in breast cancer patients
receiving radiation therapy (Toma et al., 2010) and T cells
can readily be isolated from bronchoalveolar lavage in patients
after lung irradiation (Nakayama et al., 1996). Even radiation
doses that do not cause any obvious lung damage can ele-
vate T cell numbers in bronchoalveolar lavage fluids in mice
for a long time (Johnston et al., 2011). It is not surprising
that radiation-induced interstitial pneumonitis and alveolitis is
a common complication in syngeneic and allogeneic bone mar-
row transplantation (Shankar et al., 1999; Beyzadeoglu et al.,
2004) and that this can be exacerbated by T cell responses
to infectious agents (Bruckner et al., 2006). Cyclophosphamide
given in combination with WBI also increases the damage to
the lung and there is an inverse relationship with bone mar-
row damage (Yan et al., 1991). This reciprocal relationship might
in part be because some of the radiation-induced lung dam-
age is in fact immune-mediated, i.e., it needs the supply of
immune players from the bone marrow. In keeping with this con-
cept, thymic reprocessing seemed to enhance the incidence of
radiation-induced pneumonitis in mice as it was decreased by
thymectomy of mice receiving WBI and syngeneic bone mar-
row transplantation; an effect that was reversed by spleen cell
delivery (McBride and Vegesna, 1997, 2000). The ability of radi-
ation to cause autoimmunity was emphasized by the finding that
very high-dose, fractionated, total lymphoid irradiation (TLI)-
induced multi-organ autoimmunity in mice, with characteristics
dependent on radiation dose, extent of lymphoid irradiation,
and the genetic background (Sakaguchi et al., 1994). This con-
trasts with studies where irradiation has been used to suppress
autoimmunity.
SUPPRESSION OF AUTOIMMUNITY AFTER TISSUE
IRRADIATION
Despite the examples of radiation-induced autoimmune reactions
cited above, remarkably, WBI or TLI followed by autolo-
gous stem cell transplantation has been used to treat already-
established spontaneous autoimmune diseases such as systemic
lupus erythematosus or rheumatoid arthritis with the aim
of eliminating autoreactive lymphocytes (Loor et al., 1988).
Astonishingly, this is successful in a high proportion of patients
despite the fact that depletion of autoreactive cells is never
complete and there is always a possible contribution to fail-
ure from T cells in the autologous graft. Homeostatic expan-
sion of Tregs may contribute but success seems to be mostly
due to thymic-dependent regeneration of Tregs and repro-
gramming of the imbalanced immune networks following irra-
diation (van Wijk et al., 2008). This may take 9 months
to occur in humans and there appears to be a window
of time when tolerance can be re-established, with ongoing
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chronic inflammation and high levels of danger signaling being
negative long-term predictors for success. In mice, low repeated
doses of WBI attenuated autoimmune allergic encephalitis
by up-regulating Tregs and suppressing IL-17 production
(Tsukimoto et al., 2008), and appears to require recognition
of TNFR2 on non-hematopoietic cells by Tregs (Tsakiri et al.,
2012).
Similar immunosuppressive reprogramming can follow TLI.
This was introduced in the late 1970s by Kaplan and Strober
and later shown to be due to the generation of suppressor cells
(Waer et al., 1984). Even patients with graft failure or graft
rejection after allogeneic hematopoietic stem cell transplantation
can be rescued by TLI-based reconditioning regimens result-
ing in sustained engraftment (Heinzelmann et al., 2008). The
suppressor cells in the early preclinical studies of LTI and WBI
were induced independent of the thymus (Weigensberg et al.,
1984) and may have been myeloid or NKT cells, although the
addition of anti-thymocyte serum to LTI has more recently
documented Treg cell involvement (Nador et al., 2010). The
explanation for the apparent discrepancy in radiation both caus-
ing and treating autoimmunity may lie in whether generalized
immune reprogramming is occurring, whether the irradiation
is localized or extensive, the radiation dose, the state of the
immune system at the time of the exposure, i.e., in suppres-
sor or effector mode, and the extent and nature of the “dan-
ger” signals that are generated. The immune system is normally
in balance and this can be tipped in more than one direc-
tion depending on the therapeutic intervention. This will also
change with time as different subsets take different times to
regenerate. “Rebalancing” of course means something rather dif-
ferent if one is treating autoimmune disease as compared with
cancer treatment or after a radiological incident. The impor-
tant issue for the future is understanding the pathways involved
so that they can be manipulated appropriately for the given
situation.
RADIATION KILLS LYMPHOCYTES SELECTIVELY
Radiation is often viewed as an immune-suppressive agent and
most lymphocytes are indeed very radiation sensitive. Even local
RT will have a direct cytotoxic effect on the circulating immuno-
cyte pool as blood flows through the field, irrespective of other,
more complex effects associated with immune activation. The
extent of immune depletion will vary with the tissue, the size of
the field, the delivery schedule, and dose (MacLennan and Kay,
1978). Cranial irradiation, for instance, can cause long-term lym-
phopenia in children to an extent that depends on the number of
fractions i.e., dose (MacLennan and Kay, 1978). In reality, how-
ever, lymphocyte subsets differ in their radiation sensitivities. This
is most obvious in lethal irradiation for bone marrow precondi-
tioning, which does not eliminate all lymphocytes equally (Bagley
et al., 2002). In very general terms, a spectrum of radiosensitivity
exists from B cells through naive Th cells, NK cells, toward more
radioresistant T memory cells (Belka et al., 1999) and NKT cells
(Yao et al., 2011), and Tregs (Kachikwu et al., 2011). There is a
tendency toward apoptosis denoting a more radiosensitive phe-
notype, while non-proliferative cells and activated lymphocytes
are more radioresistant (McBride et al., 2004), although Tregs
probably gain in radiosensitivity when they are induced (Awwad
and North, 1988).
The end result is that irradiation imbalances the immune
system. This may be restored with time depending upon the
recovery time for the different immune subsets, but may also
persist for long periods or even forever as is seen in A-bomb
survivors. Since the distribution of T cell subsets is organ-
specific (Matzinger and Kamala, 2011), recovery will proceed
at different rates in different tissues and will depend on the
chemokines produced (Pelus and Fukuda, 2008). An extreme
example of this is recovery of γδTCR CD4+ intraepithelial T
cells in the gut after WBI. This is independent of the thymus
and occurs very rapidly in mice, while αβTCR T cells subsets
take several weeks to recover (Mosley and Klein, 1992). In this
analysis, the relative radiosensitivity and recovery of Tregs fol-
lowing local RT and WBI would be expected to be rapid if
this mechanism protects against radiation-induced normal tissue
damage.
TREGS AND NORMAL TISSUE RADIATION RESPONSES
Recently, Tregs have been shown to be relatively radioresis-
tant and their representation increases rapidly following irra-
diation, as might be expected if they are involved in limit-
ing damage and associated inflammation (Cao et al., 2009;
Kusunoki et al., 2010; Nakatsukasa et al., 2010; Qu et al., 2010;
Weng et al., 2010; Billiard et al., 2011; Kachikwu et al., 2011).
Further induction and activation may be through the pow-
erful immune-suppressive cytokine TGF-β (Chen et al., 2003;
Beal et al., 2012; Takahashi et al., 2012) that is induced by RT
(Martin et al., 2000), but additional mechanisms are possible.
We have shown radiation-enhanced expression of the ectonu-
cleotidase CD39 on the Treg population (Schaue, unpublished),
that was previously observed in cancer patients receiving RT
(Mandapathil et al., 2009). Nucleotide catabolism by CD39 and
CD73 with production of adenosine is probably the most prim-
itive immunosuppressive response to “danger.” Adenosine has
long been known to play a critical, non-redundant role in
the protection of normal tissues from collateral damage during
inflammation (Cronstein, 1994), including radiation-induced tis-
sue damage (Hosek et al., 1992; Pospisil et al., 1993, 1998; Hou
et al., 2007), where it plays a protective role (Hofer et al., 2002).
Support for this scenario comes from the observation that tis-
sue derived adenosine acting through its receptor A2AR drives
Tregs and limits autoimmune tissue destruction (Zarek et al.,
2008).
Importantly, Treg radiosensitivity seems to depend upon their
subtype and proliferative/activation status. This would explain
the discrepancy seen between recent findings of radio-resistant
Tregs and the radiation-sensitive Tregs first reported over 30
years ago (Hellstrom et al., 1978; Tilkin et al., 1981; North,
1986). Then, sublethal, WBI was used to eliminate suppres-
sor T cells and uncover immune-mediated mechanisms lead-
ing to tumor regression. The timing of the radiation exposure
post-tumor implantation was critical suggesting that a Treg sub-
population had been induced that was sensitive to radiation.
Although Tregs have a reputation for being relatively anergic to
antigenic stimulation in vitro, they appear to be able to proliferate
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in vivo following stimulation (Walker, 2004), which might make
them radiosensitive. The type of Treg may also be important. The
majority of Tregs are naturally occurring nTregs that come from
the thymus. Induced Tregs can arise outside the thymus from
peripheral conversion of CD4+CD25− naïve T cells. Induction
can be a result of exposure to low doses of antigen, IL-2, and
TGF-β (Apostolou and von Boehmer, 2004; Curotto de Lafaille
et al., 2004). So far it has remained difficult to definitively distin-
guish nTregs from iTregs, phenotypically and functionally, but it
is clear that they do not have the same workload when it comes to
controlling adaptive immune responses. There is some evidence
that iTregs exert control of inflammatory responses at normal
mucosal surfaces while nTregs appear more important for medi-
ating self tolerance and tumor immune escape (Sakaguchi, 2004,
2005; Curotto de Lafaille and Lafaille, 2009; Haribhai et al., 2011;
Rosenblum et al., 2011; Josefowicz et al., 2012). The differential
sensitivity of nTregs and iTregs and their proliferative versus non-
proliferative state could go a long way toward explaining some of
the divergent data emanating from studies on the effects of RT
on autoimmunity and anti-tumor responses that are described
above, although further studies are urgently needed to elucidate
the critical variables in these systems.
Taken together, the idea that radiation drives Tregs to protect
tissues against radiation damage seems plausible. Recent findings
that Tregs regulate the hematopoietic stem cell niche (Urbieta
et al., 2010) suggest an even more important role for these cells
in maintaining microenvironments that are protected from pro-
inflammatory influences and allowing them to regenerate after
irradiation. The impairment in Tregs in acquired aplastic anemia
is in keeping with this concept (Shi et al., 2012). At the same time,
the ability of HIF-1α to drive Th17 cells toward differentiation
and pro-inflammatory autoimmune responses (Pan et al., 2012),
as can IL-6 and adenosine (Wilson et al., 2011), suggests ways in
which the tissue microenvironment that is generated by irradia-
tion might negate the influence of Tregs (Radhakrishnan et al.,
2008). Other cytokines such as TGF-β, IL-1, IL-23, and TNF-α
will also influence these processes (Schaue et al., 2012). The con-
cept seems to be evolving that the balance between the normal
tissue microenvironment induced by irradiation and the immune
system is decisive in controlling the extent of damage and regener-
ation or replacement of tissue following exposure, and the degree
of local immunity that is generated.
INTERCEPTING IMMUNE MECHANISMS TO PROTECT
NORMAL TISSUES
The picture that is emerging draws a line from radiation-induced
tissue damage, the release of danger signals all the way to
inflammation and the activation of the immune system and its
immune control mechanisms, to tissue regeneration (Schaue and
McBride, 2010). The immune cells that infiltrate the damaged
area in the immediate aftermath of irradiation, as well as those
cells that were affected directly during the radiation exposure will
determine the ultimate fate of that tissue, with influence from the
genetic make-up of the host and multiple tissue-specific factors.
What is lacking is information regarding the extent of polariza-
tion within the T cell and other cellular compartments and the
associated cytokines they release that we associate with various
characteristic normal tissue side effects such as pneumonitis and
fibrosis in the lung, demyelination, gliosis and vascular damage
in the brain, erythema, desquamation, fibrosis in the skin, diar-
rhea, ulceration, and other intestinal dysfunctions (Brush et al.,
2007; Linard et al., 2012; Schaue et al., 2012). Genetics will play
a role as will standard radiobiological parameters of dose, dose
rate, volume, etc. Defining the irradiated tissue microenviron-
ment in these terms will be important if we wish to utilize the
numerous tools that could be of value in radioprotecting nor-
mal tissues, mitigating radiation-induced damage, and treating
patients with complications from RT. Tools to target pathways
involving chemokines and cytokines like TNF-α, IL-1, CSFs, IL-
6, IL-17, TGF-β, HIF-1, cell adhesion molecules, and receptors
like ICAM-1, CD11b, TLRs, transcription factors like HIF-1,
NF-κB, p53, STATs, as well as T cell subsets and immune mod-
ulatory molecules, are currently in the clinic or in the pipeline.
Conceptually, the targets are fairly obvious, but target validation
is generally poorly developed for radiation-induced normal tissue
reactions. There are risks in trying to manipulate immune control
mechanisms as was seen with TGN1412 (Hunig, 2012), however,
the potential is great and the prize could be a major increase in
radiotherapeutic benefit in cancer treatment and ways to improve
the outcome of radiological accidents and incidents.
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